DOI : 10.1055/s-00034924

Nuklearmedizin - NuclearMedicine

Issue 02 · Volume 58 · March 2019 DOI: 10.1055/s-009-42722

Deutsche Gesellschaft für Nuklearmedizin e.V.
NuklearMedizin 2019
Bremen, 03.–06.04.2019

57. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin

Kongresspräsident: Professor Dr. Michael Schäfers

P32
Nikolaus, S; Wittsack, HJ; Wickrath, F; Müller-Lutz, A; Beu, M; Antke, C; Hautzel, H; Antoch, G; Müller, HW: Amantadin reduziert das motorische und exploratorische Verhalten der Ratte in Korrelation mit der neostriatalen D2-Rezeptorbindung
P33
Deussing, M; Götzl, J; Werner, G; Sebastian, L; Kleinberger, G; Parhizkar, S; Colombo, A; Wagner, M; Winkelmann, J; Diehl-Schmid, J; Levin, J; Fellerer, K; Bultmann, S; Bartenstein, P; Rominger, A; Tahirovic, S; Butovsky, O; Capell, A; Haass, C; Brendel, M: Opposite microglial phenotypes upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism
P34
Apetz, N; Neumaier, B; Drzezga, A; Timmermann, L; Endepols, H: Modulation of brain network recruitment caused by STN DBS and L-DOPA in parkinsonian rats
P35
Müller, AG; Müller, FH; Henschel, M; Bredow, CR von; Bredow, YM von; Trenczek, TE: MR and PET imaging of the insect Manduca sexta as a new screening system for gut inflammatory compounds
P36
Mishchenko, O; Schildan, A; Sabri, O; Patt, M: Biodistribution 18F-markierter Quantum Dot-Antikörper-Biokonjugate
P37
Döring, P; Lang, CI; Gäbel, R; Vasudevan, P; Stenzel, J; Kurth, J; Bergner, C; Ince, H; Vollmar, B; David, R; Krause, BJ: Bildgebung der Angiogenese nach Herzinfarkt mittels Ga-68-NODAGA-RGD PET im Mausmodell
P38
Nauerth, A; Eigner, S; Himmelreich, U; Molinos, C; Correcher, C; Heidenreich, M; Oerther, C; Deroose, CM; Gsell, W: PET/MR – simultaneous hybrid imaging with Intragate: freezing PET cardiac and respiratory motion with MRI
P39
Miederer, I; Bausbacher, N; Mahmoud, Z; Waldmann, C; Buchholz, H; Röhrich, J; Uebbing, K; Mildenberger, P; Lutz, B; Schmitt, U; Schreckenberger, M: Einfluss chronischer THC-Gaben auf die zerebrale Glukoseaufnahme in der Ratte
P40
Wilke, S; Tiepolt, S; Rullmann, M; Meyer, PM; Hesse, S; Patt, M; Luthardt, J; Barthel, H; Wagenknecht, G; Smits, R; Hoepping, A; Sattler, B; Deuther-Conrad, W; Gertz, HJ; Brust, P; Becker, GA; Sabri, O: Comparison of the novel α4β2 nicotinic acetylcholine receptor PET radioligands (-)-Flubatine and (+)-Flubatine in Healthy Controls
P41
Poxleitner, M; Hoffmann, SH; Maurer, A; Reischl, G; Wild, AM; Griessinger, CM; Wiehr, S; Pichler, BJ; Maier, FC: Dual in vivo PET ex vivo FACS cell tracking of neutrophils – first results in a mouse model of Alzheimer disease
P42
Mann, T; Krause, BJ; Hawlitschka, A; Stenzel, J; Lindner, T; Polei, S; Hohn, A; Wree, A; Kurth, J: Continuous Blood-Sampling in small animal [18F]FDG-PET/CT measurements
P43
Deussing, M; Eckenweber, F; Blume, T; Luque, J; Sacher, C; Lindner, S; Ungern-Sternberg, B von; Unterrainer, M; Albert, NL; Zwergal, A; Bartenstein, P; Rominger, A; Höglinger, G; Herms, J; Brendel, M: Longitudinal PET Monitoring of Microglial Activation in Tau Transgenic P301S Mice Predicts Cognitive Deterioration and Metabolic Decline
P44
Lang, CI; Vasudevan, P; Gäbel, R; Döring, P; Stenzel, J; Lindner, T; Kurth, J; Vollmar, B; Ince, H; Krause, BJ; David, R: Bildgebung der zellulären Inflammation nach Herzinfarkt mittels F-18-FDG-PET als prognostischer Marker kardialer Stammzelltherapien im Mausmodell